OTCMKTS:BNKL

Bionik Laboratories - BNKL Stock Forecast, Price & News

$0.27

0.00 (0.00%)

(As of 08/12/2022 12:00 AM ET)

Add

Compare

Today's Range: $0.27
▼
$0.27
50-Day Range: $0.25
▼
$1.00
52-Week Range: $0.25
▼
$2.42

Volume: N/A
Average Volume: 165 shs
Market Capitalization: $1.83 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Bionik Laboratories (OTCMKTS:BNKL) Stock

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

Receive BNKL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionik Laboratories and its competitors with MarketBeat's FREE daily newsletter.

BNKL Stock News Headlines

August 10, 2022 | finance.yahoo.com

BIONIK Laboratories Reports First Quarter Financial Results

August 9, 2022 | tmcnet.com

BIONIK Laboratories Corp. to Present at Investor Summit Group's Q3 Virtual Conference

August 9, 2022 | finance.yahoo.com

BIONIK Laboratories Corp. to Present at Investor Summit Group’s Q3 Virtual Conference

June 23, 2022 | finance.yahoo.com

BIONIK Laboratories Announces the Sale & Installation of a New InMotion® ARM/HAND Robotic Device to Tampa General Hospital for its Rehabilitation Center

June 9, 2022 | finance.yahoo.com

BIONIK Laboratories Reports Fourth Quarter and Fiscal Year 2022 Financial Results

May 25, 2022 | finance.yahoo.com

BIONIK Laboratories: Strong Sales Pipeline Delivering Hope to Stroke Survivors

March 30, 2022 | finance.yahoo.com

BIONIK Laboratories to Attend the 2022 American Occupational Therapy Association (AOTA) Conference & Expo

March 29, 2022 | finance.yahoo.com

BIONIK Laboratories Reports 15-20% Increase in Therapeutic Gains on InMotion® Robotic Devices in New Patient Outcomes Data Report

February 9, 2022 | finance.yahoo.com

BIONIK Laboratories Reports Third Quarter Fiscal Year 2022 Financial Results

January 31, 2022 | finance.yahoo.com

BIONIK Laboratories to Participate at the American Physical Therapy Association Conference

December 18, 2021 | businesswire.com

BIONIK Laboratories InMotion® Robotics Technology Meets the Recovery Demands from an Increase of Stroke Patients Brought on by Severe Cases of COVID-19

November 11, 2021 | finance.yahoo.com

BIONIK Laboratories to Participate at MEDICA, a Leading International Trade Show for the Medical Industry

November 10, 2021 | finance.yahoo.com

BIONIK Laboratories Reports Second Quarter Fiscal Year 2022 Financial Results

October 28, 2021 | finance.yahoo.com

BIONIK Laboratories Announces Commercial Team Addition With Newly Hired Regional Sales Director, Tony Bellofatto

October 9, 2021 | nasdaq.com

Bionik Laboratories Corp Shares Close the Week 76.5% Higher - Weekly Wrap

September 22, 2021 | finance.yahoo.com

BIONIK Laboratories Reports a 72% Increase in Patient Sessions on its InMotion® Robotic Devices Since Launch of InMotion Connect™ Platform

August 12, 2021 | finance.yahoo.com

BIONIK Laboratories Reports Fiscal 2022 Q1 Financial Results

July 29, 2021 | finance.yahoo.com

BIONIK Laboratories Announces $5 Million Capital Raise through Issuance of Convertible Notes

February 11, 2021 | finance.yahoo.com

BIONIK Laboratories Reports Fiscal 2021 Q3 Financial Results

November 30, 2020 | finance.yahoo.com

BIONIK Laboratories Corp. Appoints Rich Russo, Jr. as CFO

November 12, 2020 | finance.yahoo.com

BIONIK Laboratories Announces Fiscal 2021 Q2 Financial Results

October 9, 2020 | finance.yahoo.com

BIONIK Laboratories Announces Sale of New InMotion® ARM/HAND Robotic Device to VA Rehabilitation Research & Development’s Center for Neurorestoration and Neurotechnology

September 29, 2020 | bloomberg.com

Bionik Laboratories Corp. Appoints Dr. Eric Dusseux as Chief Executive Officer

August 13, 2020 | finance.yahoo.com

BIONIK Laboratories Announces Fiscal 2021 Q1 Financial Results

June 30, 2020 | finance.yahoo.com

BIONIK Laboratories Announces Fiscal 2020 Financial Results

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive BNKL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionik Laboratories and its competitors with MarketBeat's FREE daily newsletter.

BNKL Company Calendar

Last Earnings: 6/09/2022
Today: 8/13/2022
Fiscal Year End: 3/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:BNKL
CUSIP: N/A
CIK: 1508381
Web: www.bioniklabs.com
Phone: 617-926-4800
Fax: N/A
Employees: 13
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.89)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,410,000.00
Net Margins: -1,342.13%
Pretax Margin: -1,342.13%
Return on Equity: -975.04%
Return on Assets: -87.00%

Debt

Debt-to-Equity Ratio: 0.31
Current Ratio: 2.32
Quick Ratio: 2.27

Sales & Book Value

Annual Sales: $1.27 million
Price / Sales: 1.44
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.24 per share
Price / Book: 1.13

Miscellaneous

Outstanding Shares: 6,770,000
Free Float: 4,035,000
Market Cap: $1.83 million
Optionable: Not Optionable
Beta: -0.83

Key Executives

Mr. Richard Paul Russo Jr. (Age 41)
CPA, CFO & Interim CEO
Comp: $298.6k
Mr. Michal Prywata (Age 31)
Co-Founder & Director
Comp: $585.87k

Key Competitors

View All Competitors

BNKL Stock - Frequently Asked Questions

How have BNKL shares performed in 2022?: Bionik Laboratories' stock was trading at $0.80 at the start of the year. Since then, BNKL stock has decreased by 66.2% and is now trading at $0.2701.
View the best growth stocks for 2022 here.
How were Bionik Laboratories' earnings last quarter?: Bionik Laboratories Corp. (OTCMKTS:BNKL) announced its earnings results on Thursday, June, 9th. The company reported ($0.29) earnings per share (EPS) for the quarter. The company earned $0.19 million during the quarter. Bionik Laboratories had a negative net margin of 1,342.13% and a negative trailing twelve-month return on equity of 975.04%.
What other stocks do shareholders of Bionik Laboratories own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Bionik Laboratories investors own include Co-Diagnostics (CODX), iBio (IBIO), PerkinElmer (PKI), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX) and Digital Ally (DGLY).

What is Bionik Laboratories' stock symbol?: Bionik Laboratories trades on the OTCMKTS under the ticker symbol "BNKL."
How do I buy shares of Bionik Laboratories?: Shares of BNKL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Bionik Laboratories' stock price today?: One share of BNKL stock can currently be purchased for approximately $0.27.
How much money does Bionik Laboratories make?: Bionik Laboratories (OTCMKTS:BNKL) has a market capitalization of $1.83 million and generates $1.27 million in revenue each year. The company earns $-10,410,000.00 in net income (profit) each year or ($1.89) on an earnings per share basis.
How can I contact Bionik Laboratories?: Bionik Laboratories' mailing address is 483 Bay Street N105, Toronto A6, M5G2C9. The official website for the company is www.bioniklabs.com. The company can be reached via phone at 617-926-4800 or via email at lm@bioniklabs.com.

This page (OTCMKTS:BNKL) was last updated on 8/14/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources